vida: extract claims from 2025-07-09-medrxiv-kentucky-mtm-grocery-prescription-bp-reduction-9mmhg
Some checks are pending
Sync Graph Data to teleo-app / sync (push) Waiting to run
Some checks are pending
Sync Graph Data to teleo-app / sync (push) Waiting to run
- Source: inbox/queue/2025-07-09-medrxiv-kentucky-mtm-grocery-prescription-bp-reduction-9mmhg.md - Domain: health - Claims: 2, Entities: 0 - Enrichments: 3 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida <PIPELINE>
This commit is contained in:
parent
cbe5a95eea
commit
d7dcbb1aa0
2 changed files with 34 additions and 0 deletions
|
|
@ -0,0 +1,17 @@
|
||||||
|
---
|
||||||
|
type: claim
|
||||||
|
domain: health
|
||||||
|
description: "Kentucky pilot study shows MTM and grocery prescription interventions achieve BP reductions (MTM: -9.67 mmHg, grocery: -6.89 mmHg) that match or exceed standard antihypertensive medications (-5 to -10 mmHg range)"
|
||||||
|
confidence: experimental
|
||||||
|
source: UK HealthCare + Appalachian Regional Healthcare pilot study, medRxiv preprint 2025-07-09
|
||||||
|
created: 2026-04-01
|
||||||
|
title: Medically tailored meals produce -9.67 mmHg systolic BP reductions in food-insecure hypertensive patients — comparable to first-line pharmacotherapy — suggesting dietary intervention at the level of structural food access is a clinical-grade treatment for hypertension
|
||||||
|
agent: vida
|
||||||
|
scope: causal
|
||||||
|
sourcer: UK HealthCare + Appalachian Regional Healthcare
|
||||||
|
related_claims: ["[[SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action]]", "[[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]]", "[[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035]]"]
|
||||||
|
---
|
||||||
|
|
||||||
|
# Medically tailored meals produce -9.67 mmHg systolic BP reductions in food-insecure hypertensive patients — comparable to first-line pharmacotherapy — suggesting dietary intervention at the level of structural food access is a clinical-grade treatment for hypertension
|
||||||
|
|
||||||
|
The Kentucky MTM pilot enrolled 75 food-insecure hypertensive adults across urban (UK HealthCare) and rural (Appalachian Regional Healthcare) sites. The medically tailored meals arm (5 meals/week for 12 weeks) produced -9.67 mmHg systolic BP reduction, while the grocery prescription arm ($100/month for 3 months) produced -6.89 mmHg reduction. Both exceed the 5 mmHg clinical significance threshold. Critically, these reductions fall within or exceed the -5 to -10 mmHg range typical of first-line antihypertensive pharmacotherapy. This suggests that addressing food insecurity through structured food access interventions operates as a clinical-grade treatment mechanism, not merely a lifestyle support. The effect size is particularly notable because it achieves pharmacotherapy-scale outcomes without adding a prescription drug. The mechanism appears to be direct: providing hypertension-appropriate food to food-insecure patients removes the structural barrier (lack of access to appropriate food) that prevents dietary adherence. This is distinct from education-based interventions, which assume food access exists but knowledge is lacking. The study's two-arm design also reveals a dose-response relationship: fully prepared meals (-9.67 mmHg) outperform grocery purchasing power (-6.89 mmHg), suggesting that removing both financial AND preparation barriers maximizes the effect. Important limitation: this is a 12-week pilot without durability data. The AHA Boston Food is Medicine study showed similar acute effects but full reversion by 6 months post-intervention, indicating the effect may require continuous delivery.
|
||||||
|
|
@ -0,0 +1,17 @@
|
||||||
|
---
|
||||||
|
type: claim
|
||||||
|
domain: health
|
||||||
|
description: "Appalachian rural site achieved 81% enrollment rate compared to 53% at urban Lexington site in the same MTM pilot study"
|
||||||
|
confidence: experimental
|
||||||
|
source: Kentucky MTM pilot, UK HealthCare vs. Appalachian Regional Healthcare enrollment comparison
|
||||||
|
created: 2026-04-01
|
||||||
|
title: Rural food-insecure populations enrolled in food assistance interventions at 81 percent versus 53 percent in urban settings, suggesting rural populations may be more receptive to food-based health interventions due to more severe baseline food access constraints
|
||||||
|
agent: vida
|
||||||
|
scope: correlational
|
||||||
|
sourcer: UK HealthCare + Appalachian Regional Healthcare
|
||||||
|
related_claims: ["[[SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action]]"]
|
||||||
|
---
|
||||||
|
|
||||||
|
# Rural food-insecure populations enrolled in food assistance interventions at 81 percent versus 53 percent in urban settings, suggesting rural populations may be more receptive to food-based health interventions due to more severe baseline food access constraints
|
||||||
|
|
||||||
|
The Kentucky pilot's two-site design revealed a striking enrollment disparity: Appalachian Regional Healthcare (rural) enrolled 26 of 32 referred patients (81%), while UK HealthCare (urban Lexington) enrolled 49 of 92 referred patients (53%). This 28-percentage-point gap suggests rural food-insecure populations may be substantially more receptive to food assistance interventions. The likely mechanism: rural Appalachian food access is more severely constrained due to geographic isolation, limited grocery infrastructure, and transportation barriers. When offered a food intervention, rural participants may recognize its direct value more immediately because their baseline food access is worse. This challenges the common assumption that urban populations are easier to reach for health interventions due to proximity and infrastructure. For food-specific interventions, the opposite may be true: rural populations face more severe food access constraints and therefore show higher engagement when those constraints are directly addressed. This has significant implications for targeting food-as-medicine programs — rural deployment may achieve better enrollment and engagement despite higher logistical delivery costs. The finding also suggests that rural health disparities in diet-sensitive conditions (hypertension, diabetes, cardiovascular disease) may be particularly amenable to food access interventions because the structural barrier is more severe and the intervention addresses the root constraint directly.
|
||||||
Loading…
Reference in a new issue